Joseph Schwartz

Stock Analyst at Leerink Partners

(1.29)
# 1989
Out of 5,441 analysts
182
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
KALV KalVista Pharma
Maintains: Outperform
18 20
12.52 59.74% 6 Jul 7, 2025
INSM Insmed
Maintains: Outperform
100 115
112.87 1.89% 4 Jun 10, 2025
FULC Fulcrum Therapeutics
Upgrades: Outperform
4 12
6.35 88.98% 4 May 23, 2025
RGLS Regulus Therapeutics
Downgrades: Market Perform
7
8.16 -14.22% 3 Apr 30, 2025
MAZE Maze Therapeutics
Initiates Coverage On: Outperform
28
13.47 107.87% 1 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 40
17.29 131.35% 6 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 14
n/a n/a 2 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Jul 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12 12
6.06 98.02% 6 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 8
1.51 429.8% 2 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
675 150
9.98 1403.01% 5 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
1.38 -27.54% 4 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10
18.2 -45.05% 3 Dec 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
0.88 13.64% 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
6
4.81 24.74% 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
44 40
40.39 -0.97% 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80 115
172.36 -33.28% 3 Jun 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
48
43.3 10.85% 1 Mar 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 18
20.55 -12.41% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
33 34
40.84 -16.75% 1 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
122 130
56.8 128.87% 10 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
160
17.95 791.36% 10 Jan 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
148 163
195.94 -16.81% 15 Jan 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 2
n/a n/a 6 Dec 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
1.74 474.71% 7 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 33
1.01 3167.33% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 12
11.42 5.08% 6 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 108
27.39 294.3% 6 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
64 52
51.99 0.02% 5 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 39
27.39 42.39% 1 May 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 4
0.81 393.83% 4 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 30
12.99 130.95% 2 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 50
45.74 9.31% 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 30
53.77 -44.21% 6 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
71 56
14.13 296.32% 1 May 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
124 4
n/a n/a 6 Apr 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
6.66 110.21% 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
112 100
99.99 0.01% 6 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
n/a n/a 1 Oct 23, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 12
1.89 534.92% 1 Sep 26, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
n/a n/a 1 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 May 18, 2017